MarketFriction

Chemcel Biotech Ltd

BSE 533026
Market cap₹Cr.
Not trading

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2013Mar 2014
Revenue from operations18.5821.4523.4531.4142.3247.6717.9714.48
Operating costs17.1519.1820.5528.3639.3945.2019.1814.81
EBITDA1.432.272.903.052.932.47-1.21-0.33
EBITDA margin %7.70%10.58%12.37%9.71%6.92%5.18%-6.73%-2.28%
Depreciation & amortisation0.130.120.110.100.090.080.060.05
Finance costs0.480.701.141.201.061.240.000.00
Non-operating income0.080.010.000.000.000.000.890.00
Pre-tax profit0.901.461.651.751.781.15-0.38-0.38
Effective tax rate %22.22%35.62%25.45%25.14%23.03%24.35%0.00%0.00%
Profit after tax0.700.941.231.311.370.87-0.37-0.38
Earnings per share (Rs)0.510.530.31-0.13-0.14
Paid out as dividend %95.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Revenue CAGR%-14%-33%-19%
Profit CAGR%%%-3%
Share price CAGR%%%%
Average return on equity%%%-1%
Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2013Mar 2014
Net block (property, plant)1.100.991.291.231.151.070.940.89
Capital work in progress5.800.130.007.377.377.377.377.37
Investments0.000.000.030.030.030.030.000.00
Current & other assets12.6023.7826.9938.5047.3451.6459.5163.91
Total assets19.5024.9028.3147.1355.8960.1167.8272.17
Share capital6.6510.5210.5225.9225.9227.9227.9227.92
Reserves & surplus0.461.562.7813.1314.6616.5216.2715.89
Total debt9.176.547.025.059.5910.0710.6310.58
Other liabilities & provisions3.226.287.993.035.725.6013.0017.78
Equity + liabilities19.5024.9028.3147.1355.8960.1167.8272.17
Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2013Mar 2014
Operating cash flow-5.68-6.48-14.08-4.98-3.760.08-0.13
Investing cash flow-5.795.65-8.670.250.250.030.00
Free cash flow (after capex)-11.48-0.83-21.48-4.98-3.760.08-0.13
Financing cash flow11.450.8422.684.693.48-0.100.19
Net change in cash-0.020.01-0.07-0.04-0.030.010.06
Cash conversion (OCF / EBITDA) %-397%-285%-447%-170%-141%-7%39%
Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2013Mar 2014
Return on capital employed %12.38%14.33%9.16%6.03%4.57%-0.70%
Receivable days129.66180.88175.26277.15208.89248.08839.681,132.05
Inventory days46.8048.1745.5380.07101.99
Payable days14.7631.5012.20182.92365.82
Cash cycle (days)129.66180.88175.26309.19225.57281.41736.83868.23
Working capital days183.48297.28293.40396.61349.91346.70855.931,063.49

Fundamentals

Market value₹ Cr.
Last price₹ 0.95
Book value / share₹ 15.7
Return on capital-0.70 %
Return on equity-0.86 %
Dividend yield0.00 %
Face value₹ 10.0
Revenue CAGR (TTM)-19%
Profit CAGR (TTM)-3%
Standalone figures.
Valuation
P/E, 3-year average14.84x
P/B, 3-year average0.42x
P/E, 5-year average14.84x
P/B, 5-year average0.42x
Profitability
Operating margin (excl. other income)5.18%
Operating margin (incl. other income)5.18%
EBITDA margin5.18%
Pre-tax margin2.41%
Net profit margin1.82%
ROE2.05%
ROCE4.57%
ROA1.50%
ROE, 3-year average3.50%
ROCE, 3-year average6.58%
ROA, 3-year average2.54%
ROE, 5-year average6.00%
ROCE, 5-year average9.29%
ROA, 5-year average3.30%
ROIC (approx.)3.32%
Tax rate24.35%
Growth
Sales growth (latest year)12.64%
Profit growth (latest year)-36.50%
Sales CAGR, 3 years26.68%
Sales CAGR, 5 years20.74%
Profit CAGR, 3 years-10.90%
Profit CAGR, 5 years4.44%
Per share
EPS (TTM)Rs 0.31
EPS (latest year)Rs 0.31
EPS, 3-year averageRs 0.45
EPS, 5-year averageRs 0.68
Book value per shareRs 15.92
Sales per shareRs 17.07
Cash flow per shareRs -1.35
Efficiency
Asset turnover0.79x
Fixed asset turnover44.55x
Inventory turnover8.03x
Inventory days45 days
Debtor days248 days
Debtors turnover1.47x
Leverage
Total debtRs 10 Cr
Net debtRs 10 Cr
Debt to equity0.23x
Net debt / EBITDA4.08x
Interest coverage1.93x
Owners' fund to total sources73.93%
Debt to assets16.75%
Cash flow
Operating cash flow (latest year)Rs -4 Cr
Investing cash flow (latest year)Rs 0 Cr
Financing cash flow (latest year)Rs 3 Cr
Net change in cash (latest year)Rs -0 Cr
Statement figures
Net sales (TTM)Rs 48 Cr
Net sales (latest year)Rs 48 Cr
Operating profit excl. other income (latest year)Rs 2 Cr
EBITDA (TTM)Rs 2 Cr
PBDT (TTM)Rs 1 Cr
Profit before tax (TTM)Rs 1 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 1 Cr
Net profit (latest year)Rs 1 Cr
Depreciation (TTM)Rs 0 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 43 Cr
Total expenditure (latest year)Rs 45 Cr
Total income (latest year)Rs 48 Cr
Share capitalRs 28 Cr
ReservesRs 17 Cr
Shareholders' fundsRs 44 Cr
Total assetsRs 60 Cr
Net blockRs 1 Cr
Capital work in progressRs 7 Cr
InvestmentsRs 0 Cr
ReceivablesRs 32 Cr
InventoryRs 5 Cr
Other liabilitiesRs 6 Cr
Shares outstanding (crore)2.79
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.

Red flags

F-score 3 of 8
explainWeak cash conversion Cash from operations was -643% of net profit over the last 3 years
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

No quarterly results published.

Activity

Compare
No listed peers in this industry.
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Chemcel Biotech Ltd?

Chemcel Biotech Ltd (533026) has a market capitalisation of Rs Cr. at the close.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03